| Dr Caroline Kaufman, OD | |
|
4317 Factoria Blvd Se, Suite A, Bellevue, WA 98006-1937 | |
| (425) 641-2020 | |
| (425) 641-7899 |
| Full Name | Dr Caroline Kaufman |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 30 Years |
| Location | 4317 Factoria Blvd Se, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831294503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152WC0802X | Optometrist - Corneal And Contact Management | OD3162TX (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Contact Lens Consultants Northwest | 9133424369 | 2 |
News Archive
Ethnicity and number of previous births are factors that can predict the length of time a woman will breastfeed her child. A new study published in the open access journal BMC Pediatrics has examined the effects of maternal factors and hospital infant-feeding practices on breastfeeding.
Researchers have found that a rare but hard-to-treat form of breast cancer is driven by a newly discovered gene. The gene ZNF703 is the first oncogene to be discovered in five years, and it could lead to more effective treatments down the road, Cancer Research UK said.
New research published in the Annals of the Rheumatic Diseases, shows that children whose parents have osteoarthritis of the knee are twice as likely to develop the condition themselves. This research suggests that genetic make-up plays a role in osteoarthritis development.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).
Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.
› Verified 1 days ago
| Provider Name | Contact Lens Consultants Northwest |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568579225 PECOS PAC ID: 9133424369 Enrollment ID: O20160225000535 |
News Archive
Ethnicity and number of previous births are factors that can predict the length of time a woman will breastfeed her child. A new study published in the open access journal BMC Pediatrics has examined the effects of maternal factors and hospital infant-feeding practices on breastfeeding.
Researchers have found that a rare but hard-to-treat form of breast cancer is driven by a newly discovered gene. The gene ZNF703 is the first oncogene to be discovered in five years, and it could lead to more effective treatments down the road, Cancer Research UK said.
New research published in the Annals of the Rheumatic Diseases, shows that children whose parents have osteoarthritis of the knee are twice as likely to develop the condition themselves. This research suggests that genetic make-up plays a role in osteoarthritis development.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).
Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Caroline Kaufman, OD 4317 Factoria Blvd Se, Suite A, Bellevue, WA 98006-1937 Ph: (425) 641-2020 | Dr Caroline Kaufman, OD 4317 Factoria Blvd Se, Suite A, Bellevue, WA 98006-1937 Ph: (425) 641-2020 |
News Archive
Ethnicity and number of previous births are factors that can predict the length of time a woman will breastfeed her child. A new study published in the open access journal BMC Pediatrics has examined the effects of maternal factors and hospital infant-feeding practices on breastfeeding.
Researchers have found that a rare but hard-to-treat form of breast cancer is driven by a newly discovered gene. The gene ZNF703 is the first oncogene to be discovered in five years, and it could lead to more effective treatments down the road, Cancer Research UK said.
New research published in the Annals of the Rheumatic Diseases, shows that children whose parents have osteoarthritis of the knee are twice as likely to develop the condition themselves. This research suggests that genetic make-up plays a role in osteoarthritis development.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, hysterectomy procedures as a treatment for menorrhagia and uterine fibroids will continue to decline at a rate of three percent a year through 2015. This decline is due to the growing advantages of less-invasive alternatives, primarily global endometrial ablation (GEA), and uterine artery embolization (UAE).
Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.
› Verified 1 days ago
Aimee Liu, OD Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Britlynn Chan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 11120 Ne 33rd Pl, Bellevue, WA 98004 Phone: 206-426-2584 | |
Adl Vision Llc Optometrist Medicare: Medicare Enrolled Practice Location: 15600 Ne 8th St Ste F13a, Bellevue, WA 98008 Phone: 425-641-7482 Fax: 425-505-2156 | |
Thomas Xie, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1020 108th Ave Ne Apt 1401, Bellevue, WA 98004 Phone: 347-687-0712 | |
Dr. Grant Edward Lindberg, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Joanna Stedman Haws, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12310 Ne 8th St, Suite 101, Bellevue, WA 98005 Phone: 425-455-0001 Fax: 425-462-7387 | |
Dr. Theodore Stephen Kadet, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 14030 Ne 24th St, Suite 101, Bellevue, WA 98007 Phone: 425-462-7800 Fax: 425-455-3019 |